MedPath
NMPA Approval

Peramivir Injection

国药准字H20243910

June 4, 2024

Drug Information

帕拉米韦注射液

注射剂

60ml∶0.3g(按C₁₅H₂₈N₄O₄计)

化学药品

June 4, 2024

Company Information

Applicant Company

苏州市吴中区东吴南路2-1号

Manufacturing Company

湖南省岳阳县生态工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.